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Autosomal dominant polycystic kidney disease (ADPKD), a hereditary renal disease caused by
mutations in PKD1 (85%) or PKD2 (15%), is characterized by the development of gradually
enlarging multiple renal cysts and progressive renal failure. Polycystin-1 (PC1), PKD1 gene
product, is an integral membrane glycoprotein which regulates a number of different biological
processes including cell proliferation, apoptosis, cell polarity, and tubulogenesis. PC1 is a target of
various proteolytic cleavages and proteosomal degradations, but its role in intracellular signaling
pathways remains poorly understood. Herein, we demonstrated that PC1 is a novel substrate for
μ- and m-calpains, which are calcium-dependent cysteine proteases. Overexpression of PC1
altered both Janus-activated kinase 2 (JAK2) and extracellular signal-regulated kinase (ERK)
signals, which were independently regulated by calpain-mediated PC1 degradation. They suggest
that the PC1 function on JAK2 and ERK signaling pathways might be regulated by calpains in
response to the changes in intracellular calcium concentration.
& 2013 The Authors. Published by Elsevier Inc. Open access under CC BY-NC-ND license.lsevier Inc.
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Autosomal dominant polycystic kidney disease (ADPKD) is a
common hereditary renal disease with a prevalence of one in every
400–1000 live births [1]. ADPKD is caused by mutations in either
PKD1 (16p13.3) or PKD2 (4q21-23). PKD1 encodes polycystin-1
(PC1), which is an integral membrane glycoprotein of 4302 amino
acids [2]. PC1 has 11 transmembrane domains with a large
extracellular segment. This segment has a novel combination of
protein–protein interacting domains including a cluster of 15 PKD
repeats that may mediate homophilic interactions [3]. PKD2
encodes polycystin-2 (PC2), an integral membrane protein of 968
amino acids, which is a member of the TRP-like superfamily and
supposed to act as a nonselective cation channel with a preference
of calcium [4]. The short cytoplasmic C-terminus of PC1 has been
shown to interact with PC2 [4], tuberin [5], STAT6 [6], and activates
JAK2-STAT3 [7]. The PC1-PC2 complex can regulate a number of
different biological processes including cell proliferation, apoptosis,
cell polarity, and tubulogenesis [8,9].
The hallmark of ADPKD is the progressive enlargement of
innumerable ﬂuid-ﬁlled cysts derived from tubular epithelia in
kidneys. Several lines of evidence suggest that the dysregulation
of epithelial cell growth is a key step in this process. However, the
pathogenetic mechanism of cyst formation and growth has not
been well understood. It may involve disrupted intracellular
calcium homeostasis, increased cAMP levels, and enhanced Ras/
MAPK signaling [10].
Calpain is a member of the calcium-dependent cysteine pro-
tease family that modulates various cellular actions. There are at
least 14 genes encoding the members of calpain superfamily.
Among them, μ- and m-calpain, which require a micromolar and a
millimolar concentration of calcium for activation respectively,
have been mainly studied [11,12]. It has been proposed that the
polypeptide sequence enriched in proline(P), glutamic acid(E),
serine(S), and threonine(T), known as “PEST” domain, is a target
for rapid degradation by calpain [13]. Calpain can recognize these
sequences and degrade PEST domain-containing proteins.
PC-1 has been recognized as a target of proteolytic cleavage and
proteosomal degradation. We previously demonstrated that Siah-
1 interacts with PC1, which affects its stability via the ubiquitin-
dependent proteasome pathway [14]. Further, the potential PEST
domain in the C-terminus of PC1 has been suggested as a
mediator motif of rapid degradation of PC1 [6,15]. However, the
role and degradation mechanism of PEST domain in PC1 has not
been elucidated in depth. In this study, we report for the ﬁrst time
that PEST domain in PC1 C-terminus is calpain-sensitive. The role
of calpain-mediated degradation of PC1 on regulation of JAK2 and
ERK signals is also addressed.Materials and methods
Plasmids
The cytoplasmic tail of PC1 (PC1-CT), encoding 4147–4302 amino acid
sequences of PC1, was generated by digestion of pcDNA 3.0/HA
(Invitrogen, Carlsbad, CA) with EcoRI and XhoI as previously described
[14]. PC1-CT and PC1-CT ΔPEST constructs were subcloned into pGEX-
4T-1 vector (Promega, Madison, WI). PC1-CT ΔPEST was generated bydeletion of PEST domain (4168–4183 aa) from PC1-CT. pEGFP-N3
(Clontech, Palo Alto, CA) expressing GFP protein was used as
transfection and loading control. FLAG-PKD1 [16], which encodes full
length PC1 tagging FLAG epitope at C-terminus, was kindly provided
from Gregory G. Germino (NIDDK, NIH, Bethesda, MD).
In vitro degradation reaction
HEK293 cell lines were maintained in DMEM (Gibco, New York, NY)
supplemented with 10% FBS and 1% antibiotic‐antimycotic. Then,
HEK293 cells were transfected using lipofectamine 2000 (Invitrogen)
with PC1-CT, FLAG-PKD1 constructs. In order to activate calpains, the
transfected cells were treated with CaCl2 and A23187, a calcium
ionophore, in serum-free conditions at 95% conﬂuence. For the
inhibition of calpains, calpeptin and calpain inhibitor IV (Calbiochem,
La Jolla, CA) were co-treated with CaCl2 and A23187. Chemical
reagents were purchased from Sigma (St Louis, MO).
GST-pull down assay
GST-fusion proteins, pGEX plasmids containing GST-PC1-CT, GST-
PC1-CT-ΔPEST, and GST alone, were overexpressed in Escherichia
coli DH5α and were induced with 0.2 mM isopropyl-β-D-thioga-
lactopyranoside (IPTG). Following sonication for cell lysates, GST
fusion proteins were batch-puriﬁed from extracts by binding to
Glutathione Sepharose 4B beads (Sigma) according to the manu-
facturer’s instruction.
FLAG tagged full length PC1 puriﬁcation and reaction with
puriﬁed calpains
FLAG-PKD1 was transfected into HEK293 cells, and then full length
PC1 tagging FLAG epitope at C-terminus was immunoprecipitated by
FLAG-M2 agarose conjugating FLAG antibody (Sigma). To elute full
length PC1, it was incubated in 0.1 M glycine–HCl (pH 3.5) for 10min.
Proteins and CaCl2 (750 μM for μ-calpain or 5 mM for m-calpain)
were incubated in a reaction mixture (30mM Tris–HCl (pH 7.5) and
1.5 mM dithiothreitol) at 30 1C for 20min. After incubation, reactions
were terminated by adding SDS sample buffer.
Mouse embryo ﬁbroblast (MEF) isolation
Primary MEF cells were isolated from either E11.5 Pkd1/ or
Pkd1þ/þ mouse embryos. Harvested embryos were dissected and
digested with trypsin-EDTA for 20 min at 37 1C. Primary MEF cells
were cultured in DMEM (Gibco) with 10% FBS in a humidiﬁed
incubator with 5% CO2 and 95% air, and the cells were used for
Western blot analysis at passage 1–2.
Western blot analysis
Anti-ERK, phospho-ERK, JAK2, phospho-JAK2, GFP antibodies were
purchased from Santa Cruz Biotechnology (Santa Cruz, CA), anti-FLAG
and β-actin antibodies from Sigma, and anti-μ-calpain antibody from
Cell Signaling Technology (Beverly, MA). Proteins puriﬁed from
transfected cells were separated by SDS-PAGE and transferred to
nitrocellulose ﬁlters. The membrane-bound antibodies were visua-
lized by the enhanced chemiluminescence (ECL) detection system
(Amersham Bioscience, Buckinghamshire, UK).
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The cytoplasmic tail of PC1 contains a calpain-sensitive
PEST sequence
Since potential PEST domain at PC1 C-terminus has been reported
without any functional study [15], we focused on the role of PEST
domain at PC1. To conﬁrm that PC1 contains a PEST domain, the
web-based algorithm called PEST-FIND was used [17]. PEST-FIND
produces a score ranging from 50 to þ50. By deﬁnition, a score
above zero denotes a possible PEST region, but a value greater
than þ5 sparks real interest. The annotated region in Fig. 1A was
found to be 16 amino acids between positions 4168–4183 of PC1
showing þ5.76 PEST-FIND score.
Rogers et al. [17] have suggested that PEST domain may be required
for rapid degradation by calpains, which are calcium dependent
proteases. To determine whether the PEST domain in PC1-CT is
susceptible for calpain-mediated degradation, we induced calpain
activation by treating PC1-CT transfected HEK293 cells with CaCl2 and
a calcium ionophore A23187. We assumed that μ-calpain would be
activated at the lower concentration of intracellular calcium level
(4 μM of A23187 for 2 h, Fig. 1B) whereas m-calpain will be only
activated at the higher concentration of intracellular calcium level
(10 μM of A23187 for 4 h, Fig. 1C). Then we treated cells with
calpain inhibitors, calpeptin and calpain inhibitor IV. Calpeptin isFig. 1 – The cytoplasmic tail of PC1 (PC1-CT) was degraded by calpai
domain is depicted as a shaded box. (B and C) Western blot analys
transfected with PC1-CT plasmid and GFP empty vector as a control
Ca2þ and A23187, a calcium ionophore, for 2 h (B) and 4 h (C). B and
was inhibited by treatment of calpeptin, an inhibitor of μ- and m-calp
(D) PEST domain-mediated degradation by calpains. Degradation of
transfection and loading control.a cell permeable calpain inhibitor which inhibits both μ- and
m-calpain, whereas calpain inhibitor IV is a speciﬁc inhibitor only
for m-calpain. As shown in Fig. 1B-lane 2, the degradation of
PC1-CT was observed by treatment with CaCl2 and A23187, and it
was recovered by treatment with calpeptin but not by calpain
inhibitor IV (Fig. 1B-lane 3 and lane 4, respectively). This ﬁnding
tells us that degradation of PC1-CT at the condition indicated in
Fig. 1B was induced mainly by μ-calpain. On the other hand, when
we treated PC1-CT transfected cells with higher concentration of
A23187 (10 μM) for longer time (4 h), PC1-CT band was recovered
both by treatment with calpeptin and calpain inhibitor IV. Indeed,
this indicates us that PC1-CT was degraded mainly by m-calpain
at the condition indicated in Fig. 1C. As shown in Fig. 1D, we could
not observe the degradation of PC1-CT without PEST domain even
at the conditions that activate either μ- or m-calpain. Taken
together, these results suggest that PC1-CT is degraded by both
μ- and m-calpain and that the PEST domain is required for the
calpain-mediated PC1-CT degradation.PC1 is degraded by μ- and m-calpain through PEST domain
in vitro
To determine whether the degradation of PC1-CT is caused by
calpains in vitro, GST-PC1-CT was constructed (Fig. 2A) and reacted
with μ- and m-calpain at the different calcium concentrations (Fig. 2Bns. (A) Location of PEST domain within PC1-CT. A potential PEST
es of the degradation of PC1-CT by calpains. HEK293 cells were
. After 48 h, cells were treated with indicated concentrations of
C show the degradation of PC1-CT. The degradation of PC1-CT
ain, and calpain inhibitor IV, a speciﬁc inhibitor of m-calpain (C).
PC1-CT by calpains required PEST domain. GFP was used as the
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Fig. 2 – In vitro degradation of GST-PC1-CT by μ-calpain and m-calpain. (A) Coomassie Blue staining of puriﬁed GST fusion proteins,
GST alone, GST-PC1-CT, and GST-PC1-CT-ΔPEST. (B) Degradation of GST-PC1-CT by μ-calpain. Degradation of GST-PC1-CT was
inhibited by treatment of 5 mM EGTA, calcium chelator (upper panel). Degradation of GST-PC1-CT was blocked by calpeptin
treatment (lower panel). (C) Degradation of GST-PC1-CT by m-calpain. Degradation of GST-PC1-CT was inhibited by treatment of
5 mM EGTA, calcium chelator (upper panel). Degradation of GST-PC1-CT was blocked by calpeptin treatment. The lowest band of
GST-PC1-CT (B) and (C) represents GST protein, and this band became larger corresponding to degradation of PC1-CT because
calpain can only degrade PC1-CT of GST-PC1-CT followed by accumulation of GST band. GST was used as a negative control (lower
panel). These data were analyzed by SDS-PAGE and Coomassie blue staining.
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degraded in a dose-dependent manner by μ-calpain. Furthermore,
the degradation of GST-PC1-CT was calcium-dependent, because
the addition of the calcium chelator EGTA to the reaction mixture
completely inhibited the degradation of GST-PC1-CT even at the
highest calpain concentration. Calpeptin also inhibited the degra-
dation of GST-PC1-CT in a dose-dependent manner (Fig. 2B, lower
panel). Similar to μ-calpain, m-calpain also degraded GST-PC1-CT
in a dose- and calcium-dependent manner (Fig. 2C). These data
indicate that PC1-CT is degraded by both μ- and m-calpain in vitro.
To further examine whether the PEST domain determines the
degradation of PC1-CT by calpains in vitro, GST-PC1-CT-ΔPEST was
constructed (Fig. 2A). The puriﬁed GST protein was used as a
negative control. GST-PC1-CT-ΔPEST was incubated with graded
concentrations of μ- and m-calpain. As shown in Fig. 2B and C,
GST-PC1-CT-ΔPEST was not degraded in contrast to GST-PC1-CT.
It indicates that the PEST domain is required for the degradation
of PC1-CT.To conﬁrm that full-length PC1 is also degraded by calpains, we
puriﬁed full-length PC1 and subsequently treated it with μ- or
m-calpain. Full-length PC1 (460 kDa) was immunoprecipitated
with FLAG antibody conjugating agarose (FLAG-M2 agarose) and
then detected by FLAG antibody (Fig. 3A). Puriﬁed full-length PC1
was reacted with μ- or m-calpain for 20 min, and then analyzed
by Western blot. Similar to GST-PC1-CT, the full-length PC1 was
also degraded by both μ- and m-calpain (Fig. 3B and C).Calpain-mediated degradation of PC1 independently
affects JAK2 and ERK signaling pathways
Since PC1 physically interacts with JAK2 and transmits its growth
inhibitory signals to the nuclei via direct activation of the
JAK-STAT pathway [18], we postulated that calpain-mediated pro-
teolysis of PC1-CT may reduce JAK2 phosphorylation. In addition,
since PC1 regulates ERK phosphorylation to control cell size [19],
Fig. 3 – In vitro degradation of full-length PC1 by calpains.
(A) Puriﬁcation of FLAG-tagged full-length PC1 using FLAG-M2
agarose bead. Puriﬁed full-length PC1 was detected by Western
blot analysis using anti-FLAG antibody. The CTF, which is
generated by the cleavage at GPS, could not be seen in this
experiment since the band representing CTF (150 kDa) was
already run out from the 4% gel. (B) Full-length PC1 was
degraded by μ-calpain (50 ng). (C) Full-length PC1 was also
degraded by m-calpain (100 ng).
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calpain-mediated PC1 degradation. Firstly, recombinant PC1 was
overexpressed in HEK293 cells, and phosphorylation of JAK2 and
ERK was detected by Western blot. As expected, JAK2 phosphor-
ylation was increased, while ERK phosphorylation was decreased
in PC1 overexpressed cells (Fig. 4A). The regulation of JAK2 and
ERK by PC1 was further conﬁrmed using MEF cells isolated from
Pkd1 / mice, and we observed down-regulation of phosphory-
lated JAK2 (pJAK2) and up-regulation of phosphorylated ERK
(pERK) in Pkd1 / MEF cells (Fig. 4C). Interestingly, the calpain-
mediated degradation of PC1 reversed the regulatory effects of
PC1 on JAK2 and ERK (Fig. 4B and C). To activate endogenous
μ-calpain, we added A23187 to FLAG-PKD1 plasmid transfected
HEK293 cells and detected autolysed μ-calpain, which indicates
μ-calpain activation since autoproteolysis of μ-calpain occurs at the
amino-terminal region and generates cleaved activated μ-calpain
in the presence of calcium. As shown in Fig. 4B, pERK was
increased whereas pJAK2 was decreased at the condition degrad-
ing both full-length PC1 (450 kDa) and the C-terminal fragment
(CTF, 150 kDa), which is generated by the cleavage at G-protein
coupled proteolytic site (GPS) [20]. Consistent results were
observed with Pkd1þ/þ MEF cells, and those effects were recov-
ered by treatment with calpeptin suggesting that calpains play
crucial roles in regulation of JAK2 and ERK by PC1 (Fig. 4C). Since
JAK2 was suggested to negatively regulate ERK [21], we examined
whether JAK2 and ERK signal changes were correlated each other
in the presence of PC1. To address this question, we induced
calpain-mediated degradation of PC1 using A23187 and then
treated JAK2 inhibitor II (Fig. 4D). Though activated μ-calpain
degraded PC1 (data not shown), JAK2 inhibition had no effect on
ERK phosphorylation (Fig. 4D). The data demonstrate that JAK-
STAT and ERK pathways may be independently controlled by PC1
in response to the changes in intracellular calcium level.Discussion
PC1 is a target for a series of proteolytic cleavage events that release
several fragments with different size. Cleaved fragments can enter the
nucleus where they bind various transcription factors to affect
downstream signaling pathways [9]. On the other hand, we pre-
viously demonstrated that PC1 is also a target for proteosomal
degradation mediated by Siah-1, which interacts with C-terminal
domain of PC1 [14]. In addition, a rapid degradation of PC1 has been
speculated through the presence of potential PEST domain contained
in the PC1 C-terminus [6,15]. However, the exact mechanism and role
of PEST domain on PC1 degradation have not been studied in depth.
In this study, we showed a ubiquitin-independent degradation of
PC1. We found that PC1 is a novel substrate for μ- and m-calpains,
which are nonlysosomal, calcium-activated cysteine proteases. It was
clearly shown that activated calpains directly recognize PEST domain
at cytoplasmic tail of PC1. Calcium is not only an important mediator
to activate calpain but also a universal secondary messenger in many
signal transduction pathways [22]. Indeed, disturbance in calcium
homeostasis caused by the mutations either in PKD1 or PKD2 induces
dysregulation of various signaling pathways and abnormal cell
functions in PKD [22–24]. Therefore, we speculated that calpain-
mediated PC1 degradation may be implicated in the control of
signaling pathways rather than the removal of useless proteins.
PC1 is constitutively bound to JAK2, but JAK2 becomes activated
only when PC1 is co-expressed with PC2 [18]. Overexpression of PC1
transmits its growth inhibitory signals from the cell surface to the
nucleus via direct activation of the JAK-STAT pathway. This, in turn,
increased expression of p21waf1, inducing cell cycle arrest in G0/G1.
We postulated that calpain-mediated proteolysis of PC1 would affect
the coiled-coil domain, which may result in failure to interact with
both JAK2 and PC2 and ﬁnally inhibit JAK2 phosphorylation. When
PKD1 cDNA was transfected in HEK293 cells, PC1 overexpression
induced JAK2 phosphorylation whereas treatment of CaCl2 and
A23187 in PC1 overexpressing HEK293 cells activated μ-calpain and
reduced pJAK2. Similar effects were observed with the experiments
using Pkd1þ/þ and Pkd1 / MEF cells, and either degradation of PC1
by calpains or loss of PC1(Pkd1 / MEF cells) decreased pJAK2. This
observation supports the previous ﬁnding that C-terminus of PC1
could interact with JAK2. PC1 down-regulates the mTOR pathway
through direct regulation of the ERK-speciﬁc phosphorylation sites on
tuberin (serine 664) to reduce cell sizes [19]. A recent report has also
demonstrated that the inactivation of the PKD1 gene in the kidney of
PKD1 conditional knockout mice results in massive renal cystogenesis
accompanied by increased activation of the ERK pathway [25]. Our
results also revealed that overexpression of PC1 inhibited ERK
phosphorylation independent of JAK2 signaling because JAK2 inhibi-
tion had no effect on ERK phosphorylation.
In conclusion, this study demonstrated that PEST domain of PC1
is the target of a ubiquitin-independent degradation by calpains.
The function of PC1 on JAK2 and ERK signaling pathways might be
independently regulated by calpains in response to changes in
intracellular calcium level.Declaration of interest
Authors have nothing to declare.
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